Henkel IP Holding Gmbh

Nanomab Technology Limited

Wenhua Huang

Allison Yue Xiao

Chung Lim Wong

Jie Cao

Hong Hoi Ting

Provided are an anti-Her2 nanobody and a coding sequence and the use thereof. In particular, provided is a nanobody combating human epidermal growth factor receptor-2 (Her2/ERBB2). Disclosed are the nanobody and the a gene sequence encoding the nanobody, a corresponding expression vector and a host cell capable of expressing the nanobody, and a method for producing the nanobody of the present invention and the related use thereof. The present invention may also provide an immunoconjugate of the nanobody and the use thereof, especially the use in the diagnosis and treatment of Her2 positive tumor.

Anti-Her2 nanobody and coding sequence and use thereof

Anti-Her2 single chain antibody and coding sequence and use thereof

A one-pot process for the electroless-plating of silver onto graphite powder is disclosed. No powder pretreatment steps for the graphite, which typically require filtration, washing or rinsing, are required. The inventive process comprises mixing together three reactant compositions in water: an aqueous graphite activation composition comprising graphite powder and a functional silane, a silver-plating composition comprising a silver salt and a silver complexing agent, and a reducing agent composition.

Electroless plating of silver onto graphite

Growing community of inventors

Shanghai, China

Wenhua Huang